Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Infection and Immunity logoLink to Infection and Immunity
. 1995 Jul;63(7):2537–2540. doi: 10.1128/iai.63.7.2537-2540.1995

Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation.

G Z Jiang 1, T Sugiyama 1, Y Kato 1, N Koide 1, T Yokochi 1
PMCID: PMC173339  PMID: 7540596

Abstract

Lipopolysaccharide from Klebsiella pneumoniae O3, which possesses the mannose homopolysaccharide as the O-specific polysaccharide, exhibits an extraordinarily high ability to activate the human complement system. We isolated the mannose-binding protein with a Klebsiella O3 lipopolysaccharide affinity column. The protein isolated had a molecular mass of much higher than 200 kDa, and it consisted of subunits with an apparent molecular mass of 32 kDa. The NH2-terminal sequence of the 32-kDa subunits was completely consistent with a part of the amino acid sequence of human serum mannose-binding protein. In immunoblotting, an anti-mannose-binding protein monoclonal antibody was definitely reactive with the isolated protein with the higher molecular mass. The protein isolated was bound exclusively to lipopolysaccharides possessing the mannose homopolysaccharide, not to lipopolysaccharide possessing the heteropolysaccharides. Klebsiella O3 lipopolysaccharide did not exhibit a high anticomplement activity in the serum from which the mannose-binding protein was depleted. It was concluded that the serum factor that bound to Klebsiella O3 lipopolysaccharide may be mannose-binding protein and that it may play a crucial role in the strong complement activation by Klebsiella O3 lipopolysaccharide.

Full Text

The Full Text of this article is available as a PDF (195.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brade L., Brade H. A 28,000-dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopolysaccharide. Infect Immun. 1985 Dec;50(3):687–694. doi: 10.1128/iai.50.3.687-694.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Curvall M., Lindberg B., Lönngren J., Nimmich W. Structural studies on the Klebsiella O group 3 lipopolysaccharide. Acta Chem Scand. 1973;27(7):2645–2649. doi: 10.3891/acta.chem.scand.27-2645. [DOI] [PubMed] [Google Scholar]
  3. Ezekowitz R. A., Kuhlman M., Groopman J. E., Byrn R. A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med. 1989 Jan 1;169(1):185–196. doi: 10.1084/jem.169.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fox J., Hechemy K. Coupling of Escherichia coli lipopolysaccharide to epoxy-activated Sepharose 6B. Infect Immun. 1978 Jun;20(3):867–868. doi: 10.1128/iai.20.3.867-868.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ihara S., Takahashi A., Hatsuse H., Sumitomo K., Doi K., Kawakami M. Major component of Ra-reactive factor, a complement-activating bactericidal protein, in mouse serum. J Immunol. 1991 Mar 15;146(6):1874–1879. [PubMed] [Google Scholar]
  6. Ji Y. H., Fujita T., Hatsuse H., Takahashi A., Matsushita M., Kawakami M. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor. J Immunol. 1993 Jan 15;150(2):571–578. [PubMed] [Google Scholar]
  7. Joiner K. A., Grossman N., Schmetz M., Leive L. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol. 1986 Jan;136(2):710–715. [PubMed] [Google Scholar]
  8. Kawakami M., Ihara I., Ihara S., Suzuki A., Fukui K. A group of bactericidal factors conserved by vertebrates for more than 300 million years. J Immunol. 1984 May;132(5):2578–2581. [PubMed] [Google Scholar]
  9. Kawasaki N., Kawasaki T., Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J Biochem. 1983 Sep;94(3):937–947. doi: 10.1093/oxfordjournals.jbchem.a134437. [DOI] [PubMed] [Google Scholar]
  10. Kuhlman M., Joiner K., Ezekowitz R. A. The human mannose-binding protein functions as an opsonin. J Exp Med. 1989 May 1;169(5):1733–1745. doi: 10.1084/jem.169.5.1733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lu J. H., Thiel S., Wiedemann H., Timpl R., Reid K. B. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol. 1990 Mar 15;144(6):2287–2294. [PubMed] [Google Scholar]
  12. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem. 1987 Jul 25;262(21):10035–10038. [PubMed] [Google Scholar]
  13. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med. 1992 Dec 1;176(6):1497–1502. doi: 10.1084/jem.176.6.1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Matsushita M., Takahashi A., Hatsuse H., Kawakami M., Fujita T. Human mannose-binding protein is identical to a component of Ra-reactive factor. Biochem Biophys Res Commun. 1992 Mar 16;183(2):645–651. doi: 10.1016/0006-291x(92)90531-o. [DOI] [PubMed] [Google Scholar]
  15. Morrison D. C., Kline L. F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977 Jan;118(1):362–368. [PubMed] [Google Scholar]
  16. Ohta M., Okada M., Yamashina I., Kawasaki T. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J Biol Chem. 1990 Feb 5;265(4):1980–1984. [PubMed] [Google Scholar]
  17. Schweinle J. E., Ezekowitz R. A., Tenner A. J., Kuhlman M., Joiner K. A. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J Clin Invest. 1989 Dec;84(6):1821–1829. doi: 10.1172/JCI114367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Summerfield J. A., Taylor M. E. Mannose-binding proteins in human serum: identification of mannose-specific immunoglobulins and a calcium-dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochim Biophys Acta. 1986 Sep 4;883(2):197–206. doi: 10.1016/0304-4165(86)90309-0. [DOI] [PubMed] [Google Scholar]
  19. Takahashi K., Fukada M., Kawai M., Yokochi T. Detection of lipopolysaccharide (LPS) and identification of its serotype by an enzyme-linked immunosorbent assay (ELISA) using poly-L-lysine. J Immunol Methods. 1992 Aug 30;153(1-2):67–71. doi: 10.1016/0022-1759(92)90306-e. [DOI] [PubMed] [Google Scholar]
  20. Taylor M. E., Brickell P. M., Craig R. K., Summerfield J. A. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J. 1989 Sep 15;262(3):763–771. doi: 10.1042/bj2620763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yokochi T., Fujii Y., Nakashima I., Asai J., Kiuchi M., Kojima K., Kato N. A murine model of experimental autoimmune lens-induced uveitis using Klebsiella O3 lipopolysaccharide as a potent immunological adjuvant. Int J Exp Pathol. 1993 Dec;74(6):573–582. [PMC free article] [PubMed] [Google Scholar]
  22. Yokochi T., Fukada M., Kawai M., Zhang Y. H., Jiang G. Z., Takahashi K. Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice. Infect Immun. 1992 Nov;60(11):4953–4956. doi: 10.1128/iai.60.11.4953-4956.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Yokochi T., Ikeda H., Inoue Y., Kimura Y., Ito H., Fujii Y., Kato N. Characterization of autoantigens relevant to experimental autoimmune orchitis (EAO) in mice immunized with a mixture of syngeneic testis homogenate and Klebsiella O3 lipopolysaccharide. Am J Reprod Immunol. 1990 Jan-Feb;22(1-2):42–48. doi: 10.1111/j.1600-0897.1990.tb01030.x. [DOI] [PubMed] [Google Scholar]
  24. Yokochi T., Inoue Y., Kimura Y., Kato N. Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action. J Immunol. 1990 Apr 15;144(8):3106–3110. [PubMed] [Google Scholar]
  25. Yokochi T., Inoue Y., Yokoo J., Kimura Y., Kato N. Retention of bacterial lipopolysaccharide at the site of subcutaneous injection. Infect Immun. 1989 Jun;57(6):1786–1791. doi: 10.1128/iai.57.6.1786-1791.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES